Human immunodeficiency virus and renal transplantation
Author(s) -
Rajani Dinavahi,
Anita Mehrotra,
Barbara Murphy,
Shirish Huprikar
Publication year - 2009
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2009.184
Subject(s) - transplantation , human immunodeficiency virus (hiv) , medicine , virology , kidney transplantation , immunology , intensive care medicine
CASE PRESENTATIONA 48-year-old African-American man with chronic human immunodeficiency virus (HIV) infection since 1987 was referred to our center for renal transplant evaluation. HIV-associated nephropathy had been diagnosed 8 years earlier by renal biopsy. Hemodialysis had been initiated 3 years earlier. Past medical history was significant for hypertension and hyperlipidemia. Before transplantation, total cholesterol was 178mg per 100ml, low-density lipoprotein was 40mg per 100ml, and high-density lipoprotein was 67mg per 100ml without lipid-lowering therapy. The patient reported no history of earlier opportunistic infection (OI), malignancy, or co-infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). He had been treated with highly active antiretroviral therapy (HAART) since 1990. After numerous treatment failures, virologic suppression was finally achieved with a combination of lamivudine, abacavir, efavirenz, and lopinavir/ritonavir
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom